Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TATA-box binding protein associated factor 13 pseudogene 2 (TAF13P2) is annotated as a pseudogene, meaning it is a non-functional genomic sequence similar to the protein-coding TAF13 gene but does not encode a functional protein[6][4]. TAF13P2 has no known biological function, molecular activity, or role as a drug target. It has no described disease associations, nor does it interact with drugs or serve as a biomarker. Its only significance is as a noncoding genomic element related in sequence to the functional TAF13 gene, which is a component of the transcription factor IID (TFIID) complex essential for RNA polymerase II transcription[6][4]. Note: - There is nothing to suggest TAF13P2 is a therapeutic target, druggable protein, or disease-associated locus. It is a processed pseudogene—functionally inert in protein-coding and signaling roles. - If you intended to refer to the functional TAF13 gene/protein, please clarify; TAF13 itself is involved in transcriptional regulation but TAF13P2 is not[1][2][6].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TATA-box binding protein associated factor 13 pseudogene 2 (TAF13P2).